Literature DB >> 2536404

Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.

J Jackson1, R B Sim, K Whaley, C Feighery.   

Abstract

C1-inhibitor (C1-Inh) is an important inhibitor of the inflammatory response and deficiency of this inhibitor, which may be hereditary or acquired, is associated with recurrent episodes of edema. Recently, an autoimmune form of angioedema has been described that is associated with functional deficiency of C1-Inh and an autoantibody that impedes C1-Inh function. In this report we describe the isolation of C1-Inh from the monocytes and plasma of a patient with autoimmune angioedema and demonstrate that the patient's monocytes secrete structurally and functionally normal C1-Inh, but show that this protein circulates in the patient's plasma in an inactive, structurally altered form. Furthermore, using analytic gel electrophoresis techniques it is demonstrated that the patient's autoantibody facilitates cleavage of normal C1-Inh, by its target proteases, to the same species of C1-Inh that is found circulating in the patient's plasma. This autoantibody facilitated cleavage of normal C1-Inh is apparently a consequence of destabilization of protease/inhibitor complexes. These findings contribute to our understanding of protease/C1-Inh interactions and document important observations on pathogenic mechanisms in autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536404      PMCID: PMC303731          DOI: 10.1172/JCI113934

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily.

Authors:  M Tosi; C Duponchel; P Bourgarel; M Colomb; T Meo
Journal:  Gene       Date:  1986       Impact factor: 3.688

2.  Complement-subcomponent-C1-inhibitor synthesis by human monocytes.

Authors:  A C Yeung Laiwah; L Jones; A O Hamilton; K Whaley
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

3.  The challenge of hereditary angioneurotic edema.

Authors:  V H Donaldson
Journal:  N Engl J Med       Date:  1983-05-05       Impact factor: 91.245

4.  Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome.

Authors:  A L Sheffer; K F Austen; F S Rosen; D T Fearon
Journal:  J Allergy Clin Immunol       Date:  1985-06       Impact factor: 10.793

5.  Human C1 inhibitor: improved isolation and preliminary structural characterization.

Authors:  R A Harrison
Journal:  Biochemistry       Date:  1983-10-11       Impact factor: 3.162

6.  Human plasma kallikrein and C1 inhibitor form a complex possessing an epitope that is not detectable on the parent molecules: demonstration using a monoclonal antibody.

Authors:  A de Agostini; M Schapira; Y T Wachtfogel; R W Colman; S Carrel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  The effect of C1 inhibitor upon Hageman factor autoactivation.

Authors:  R Weiss; M Silverberg; A P Kaplan
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

8.  Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.

Authors:  V H Donaldson; R A Harrison; F S Rosen; D H Bing; G Kindness; J Canar; C J Wagner; S Awad
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

9.  Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins.

Authors:  R S Geha; I Quinti; K F Austen; M Cicardi; A Sheffer; F S Rosen
Journal:  N Engl J Med       Date:  1985-02-28       Impact factor: 91.245

10.  Primary structure of the reactive site of human C1-inhibitor.

Authors:  G S Salvesen; J J Catanese; L F Kress; J Travis
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

View more
  8 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

Review 2.  Antibody molecules: mediators of disease and diagnostic tools.

Authors:  C Feighery
Journal:  Ir J Med Sci       Date:  1989-10       Impact factor: 1.568

3.  Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.

Authors:  E M Wallace; S J Perkins; R B Sim; A C Willis; C Feighery; J Jackson
Journal:  Mol Med       Date:  1997-06       Impact factor: 6.354

4.  Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.

Authors:  S He; R B Sim; K Whaley
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

5.  The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.

Authors:  Isabelle Schepens; Fabienne Jaunin; Nadja Begre; Ursula Läderach; Katrin Marcus; Takashi Hashimoto; Bertrand Favre; Luca Borradori
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

Review 6.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Authors:  Federica Defendi; Nicole M Thielens; Giovanna Clavarino; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

7.  Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema.

Authors:  Ravdeep Kaur; Aerik Anthony Williams; Catherine Baker Swift; Jason W Caldwell
Journal:  J Asthma Allergy       Date:  2014-12-02

8.  Angioedema.

Authors:  Allen P Kaplan
Journal:  World Allergy Organ J       Date:  2008-06       Impact factor: 4.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.